Diabetic Retinopathy

Photocoagulation — the mainstream pathway

Laser photocoagulation delivered by Ellex's Integre Pro^TM continues to be a mainstream treatment pathway, and the importance of the approach has grown with the introduction of pattern scanning photocoagulation — exemplified within our Integre Pro Scan^TM model — which transforms the efficacy and efficiency of treatment.

Retinal rejuvenation — the next step

With the development of Ellex 2RT™, which utilizes an ultra-short nanosecond laser pulse with a unique pixelated beam profile, it’s possible to effectively treat Clinically Significant Macular Edema (CSME) secondary to diabetic retinopathy, with the added benefit of sparing the photoreceptors, and therefore retinal function, from thermal damage. Using 500 times less energy than retinal photocoagulation, and without the incidence of thermal damage, 2RT™ represents a breakthrough in the laser-based treatment of CSME.^{1, 2}

1. Pelosini L. et al., RETINA REJUVENATION THERAPY FOR DIABETIC MACULAR EDEMA A Pilot Study, Retina 0:1-11,2012

2. Casson RJ. Et al., “Pilot randomized trial of a nanopulse retinal laser versus conventional photocoagulation for the treatment of diabetic macular oedema”, Clin Experiment Ophthalmol. 2012 Aug;40(6):604-10

Patient Information

Physician Resources